RSS Atom • ISSN 1472-4683 • Subscribe • About
2001
- 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Athens, 23-26 October 2001 Conference reports - Conference index - Lipodystrophy Workshop (IWADRLH) 3 Athens 2001 - 9 December 2001
- Insulin resistance Conference reports - Lipodystrophy Workshop (IWADRLH) 3 Athens 2001 - 9 December 2001
- Thyroid function abnormalities Conference reports - Lipodystrophy Workshop (IWADRLH) 3 Athens 2001 - 9 December 2001
- Lipodystrophy and metabolic changes in children Conference reports - Paediatric care - Lipodystrophy Workshop (IWADRLH) 3 Athens 2001 - 9 December 2001
- Bone studies at lipodystrophy workshop Conference reports - Lipodystrophy Workshop (IWADRLH) 3 Athens 2001 - 9 December 2001
- Survey reveals pregnant Zambians support universal nevirapine treatment Treatment access - 9 December 2001
- Caution needed with nelfinavir and some lipid-lowering drugs PK and drug interactions - 9 December 2001
- Syncytium inducing viral phenotype halves thymic T cell production in children Paediatric care - 9 December 2001
- Children with advanced disease who take HAART experience immune reconstitution Paediatric care - 9 December 2001
- New US guidelines for the prevention of opportunistic infections in people infected with HIV Guidelines - 9 December 2001
- Incidence and prognosis of AIDS-related lymphoma have improved since the advent of HAART Opportunistic infections and complications - 9 December 2001
- Detailed picture emerges of how HIV travels into and out of cells Basic science and immunology - 9 December 2001
- High levels of HIV replication shut down anti-HIV immune responses Basic science and immunology - 9 December 2001
- Natural killer cell activity varies with viral burden in HIV-1 infection Basic science and immunology - 9 December 2001
- 8th European Conference on Clinical Aspects and Treatment of HIV-infection, Athens, 28-31 October 2001 Conference reports - Conference index - EACS 8 Athens 2001 - 2 November 2001
- HIV drug resistance can develop under HAART at low levels of viraemia Conference reports - Resistance - EACS 8 Athens 2001 - 2 November 2001
- Combinations of lopinavir/r and amprenavir in heavily treatment experienced patients Conference reports - PK and drug interactions - EACS 8 Athens 2001 - 2 November 2001
- GigaHAART study shows benefit of treatment interruption prior to treatment with >7 drugs in highly treatment experienced patients Conference reports - Resistance - EACS 8 Athens 2001 - 2 November 2001
- No significant drug interactions found between tenofovir DF and indinavir, lopinavir/r, lamivudine, or efavirenz Conference reports - PK and drug interactions - EACS 8 Athens 2001 - 2 November 2001
- Ritonavir corrects drug interaction between efavirenz and saquinavir Conference reports - PK and drug interactions - EACS 8 Athens 2001 - 2 November 2001
- Lopinavir/r effective in naive patients after three years of treatment Conference reports - EACS 8 Athens 2001 - 2 November 2001
- Preventable factors linked to indinavir-associated renal complications Side effects - 2 November 2001
- Rapidly progressive HIV case highlights importance of specific immune response Basic science and immunology - 2 November 2001
- CCR5 density on T cells directly correlates with HIV disease progression Basic science and immunology - 2 November 2001
- Human herpes virus 6 prevents CCR5 tropic HIV from spreading in human tissue cultures Basic science and immunology - 2 November 2001
- HIV infection may trigger neurologic disorder Opportunistic infections and complications - 2 November 2001
- Nerve growth factor improves HIV-associated sensory neuropathy Opportunistic infections and complications - Side effects - 2 November 2001
- Daily injection more effective than thrice-weekly interferon alpha-2b for HCV/HIV Hepatitis coinfection - 2 November 2001
- Rapidly ascending neuromuscular weakness associated with nucleoside analogues Side effects - Treatment alerts - 2 October 2001
- Resistance to nevirapine differs by HIV-1 subtype PMTCT and maternal health - Resistance - 1 October 2001
- Aminoperazine shows promise in enhancing immune response of HIV patients Treatment strategies - 1 October 2001
- Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection Basic science and immunology - 1 October 2001
- Lymphocyte receptor pattern heightens susceptibility of GI mucosa to HIV Basic science and immunology - 1 October 2001
- Acceleration of increasing plasma HIV RNA load signals incipient progression Basic science and immunology - 1 October 2001
- NIMH scientists find new details of HIV viral reproduction process Basic science and immunology - 1 October 2001
- CCR5 density on T cells directly correlates with HIV disease progression Basic science and immunology - 1 October 2001
- AIDS virus's ability to mimic other infections weakens the body's defences against disease Basic science and immunology - 1 October 2001
- Metabolic abnormalities in children treated and not treated with protease inhibitors Paediatric care - 1 October 2001
- Early treatment with interferon alpha-2b can prevent chronic liver disease in those with hepatitis C Hepatitis coinfection - 1 October 2001
- Harmless hepatitis-type virus seems to extend lives of HIV-positive individuals Hepatitis coinfection - 1 October 2001
- Adefovir dipivoxil promising for lamivudine-resistant HBV in HIV-1 infected patients Hepatitis coinfection - 1 October 2001
- Severe hepatic injury common after HAART initiation Hepatitis coinfection - Side effects - 1 October 2001
- AIDS-related lymphoma responds best to chemotherapy/HAART combination Opportunistic infections and complications - 1 October 2001
- Imiquimod and drug resistant herpes simplex Opportunistic infections and complications - 1 October 2001
- Can low-dose shark cartilage shrink KS? Cancer and HIV - Opportunistic infections and complications - 1 October 2001
- Respiratory failure in PCP patients can recur after HAART initiated Opportunistic infections and complications - 1 October 2001
- Valcyte receives Dutch regulatory approval for treatment of AIDS-related CMV retinitis Opportunistic infections and complications - 1 October 2001